Skip to content

Clinical trials

Terminated Carcinoma, Hepatocellular trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Terminated Country / region: Italy Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20071
20082
20101
20112
20121
20143
20191
20202
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Istituto Clinico Humanitas2
Pfizer2
Abbott1
Astellas Pharma Inc1
Azienda Ospedaliera San Giovanni Battista1
Boston Scientific Corporation1
Kymab Limited1
Merck Sharp & Dohme LLC1
Merit Medical Systems, Inc.1
Polaris Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular16
Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Colorectal Neoplasms3
Stomach Neoplasms3
Carcinoma, Renal Cell2
Esophageal Neoplasms2
Liver Neoplasms2
Melanoma2
Neoplasm Metastasis2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.